[3-Methylglutaconic aciduria]. 1987

P Vakkuri, and E Airaksinen, and P Karttunen, and J Ollikainen, and L Pääkkönen, and J Ruostesuo, and H Ruotsalainen, and A Ruokonen

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D009468 Neuromuscular Diseases A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA. Amyotonia Congenita,Oppenheim Disease,Cramp-Fasciculation Syndrome,Fasciculation-Cramp Syndrome, Benign,Foley-Denny-Brown Syndrome,Oppenheim's Disease,Benign Fasciculation-Cramp Syndrome,Benign Fasciculation-Cramp Syndromes,Cramp Fasciculation Syndrome,Cramp-Fasciculation Syndromes,Fasciculation Cramp Syndrome, Benign,Fasciculation-Cramp Syndromes, Benign,Foley Denny Brown Syndrome,Neuromuscular Disease,Oppenheims Disease,Syndrome, Cramp-Fasciculation,Syndrome, Foley-Denny-Brown,Syndromes, Cramp-Fasciculation
D005977 Glutarates Derivatives of glutaric acid (the structural formula (COO-)2C3H6), including its salts and esters. Glutarate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000138 Acidosis A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up. Metabolic Acidosis,Acidoses,Acidoses, Metabolic,Acidosis, Metabolic,Metabolic Acidoses
D000637 Transaminases A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1. Aminotransferase,Aminotransferases,Transaminase

Related Publications

P Vakkuri, and E Airaksinen, and P Karttunen, and J Ollikainen, and L Pääkkönen, and J Ruostesuo, and H Ruotsalainen, and A Ruokonen
January 1995, Brain & development,
P Vakkuri, and E Airaksinen, and P Karttunen, and J Ollikainen, and L Pääkkönen, and J Ruostesuo, and H Ruotsalainen, and A Ruokonen
March 1997, Lancet (London, England),
P Vakkuri, and E Airaksinen, and P Karttunen, and J Ollikainen, and L Pääkkönen, and J Ruostesuo, and H Ruotsalainen, and A Ruokonen
August 1976, Clinica chimica acta; international journal of clinical chemistry,
P Vakkuri, and E Airaksinen, and P Karttunen, and J Ollikainen, and L Pääkkönen, and J Ruostesuo, and H Ruotsalainen, and A Ruokonen
January 1994, Pediatric cardiology,
P Vakkuri, and E Airaksinen, and P Karttunen, and J Ollikainen, and L Pääkkönen, and J Ruostesuo, and H Ruotsalainen, and A Ruokonen
June 1992, Pediatrics,
P Vakkuri, and E Airaksinen, and P Karttunen, and J Ollikainen, and L Pääkkönen, and J Ruostesuo, and H Ruotsalainen, and A Ruokonen
October 1983, Clinica chimica acta; international journal of clinical chemistry,
P Vakkuri, and E Airaksinen, and P Karttunen, and J Ollikainen, and L Pääkkönen, and J Ruostesuo, and H Ruotsalainen, and A Ruokonen
March 2004, Acta paediatrica (Oslo, Norway : 1992),
P Vakkuri, and E Airaksinen, and P Karttunen, and J Ollikainen, and L Pääkkönen, and J Ruostesuo, and H Ruotsalainen, and A Ruokonen
October 1992, American journal of ophthalmology,
P Vakkuri, and E Airaksinen, and P Karttunen, and J Ollikainen, and L Pääkkönen, and J Ruostesuo, and H Ruotsalainen, and A Ruokonen
April 1992, Clinica chimica acta; international journal of clinical chemistry,
P Vakkuri, and E Airaksinen, and P Karttunen, and J Ollikainen, and L Pääkkönen, and J Ruostesuo, and H Ruotsalainen, and A Ruokonen
January 1993, Pediatric neurology,
Copied contents to your clipboard!